Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSCC-90011 is an inhibitor of lysine-specific demethylase 1 (LSD1; IC50 = 0.3 nM).1 It is selective for LSD1 over LSD2, monoamine oxidase A (MAO-A), and MAO-B at 10 µM. CC-90011 induces differentiation in THP-1 cells (EC50 = 7 nM) and inhibits the proliferation of NCI H1417 small cell lung cancer (SCLC) cells (EC50 = 6 nM). It also inhibits lipid accumulation induced by palmitic acid (Item No. 10006627) and oleic acid (Item Nos. 90260 | 24659) in Huh7 hepatocytes when used at a concentration of 20 µM.2 In vivo, CC-90011 (2.5 mg/kg) reduces tumor volume in an NCI H1417 mouse xenograft model.1
WARNING This product is not for human or veterinary use.
1. Discovery of CC-
2. Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD. J. Lipid Res. 65(3), 100513 (2024).